The Latest Breaking News from FDA

The virus has not yet fully settled into a pattern of seasonality and may never, experts caution.

Questions have been raised about how Australia ensures the quality of its imported medicines after a major pharmaceutical company was warned over lapses in contamination control and manufacturing practices.

U.S. health officials want to make COVID-19 vaccinations more like the annual flu shot

With rising global medical requirements and continuous technological advancements, the healthcare industry is poised to remain buoyed in the near term. Therefore, quality medical stocks Abbott Laboratories (ABT) and Varex Imaging (VREX) might be solid buys before January ends. However, avoiding fundamentally weak stock SmileDirectClub (SDC) could be wise. Read…

The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.

A ‘harmless’ sample of cells from one pig can produce millions of tons of ‘cultivated meat’ and is touted as far better for the climate

Created by chef-influencer Chef Pii, the goopy condiment was originally plagued by health and safety issues

Eli Lilly stock dipped Friday after the FDA unexpectedly rejected its request for an accelerated approval of its Alzheimer's treatment.

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

Another potential legal setback for the FDA's attempt to regulate electronic cigarettes as tobacco products.

At-home rapid tests have become a staple of COVID-19 precautions, but some experts worry that people are relying too much on these tests and that's creating a false sense of security.